According to Inogen's latest financial reports the company has a price-to-book ratio of 0.7795.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.6248 | -58.87% |
2022-12-31 | 1.52 | -27.21% |
2021-12-31 | 2.09 | -26.21% |
2020-12-31 | 2.83 | -35.25% |
2019-12-31 | 4.37 | -49.86% |
2018-12-31 | 8.71 | -20.42% |
2017-12-31 | 10.9 | 46.46% |
2016-12-31 | 7.47 | 26.3% |
2015-12-31 | 5.92 | 16.94% |
2014-12-31 | 5.06 | |
2013-12-31 | N/A | |
2012-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ResMed RMD | 7.16 | 818.10% | ๐บ๐ธ USA |
Masimo MASI | 5.28 | 577.13% | ๐บ๐ธ USA |
Chart Industries GTLS | 2.15 | 175.26% | ๐บ๐ธ USA |
Allied Healthcare Products AHPI | 0.0031 | -99.61% | ๐บ๐ธ USA |
Philips PHG | 1.45 | 86.21% | ๐ณ๐ฑ Netherlands |